There is no upcoming dividend defined for Galapagos.
There is no set last day on which buying Galapagos shares generates the possibility of earning dividends.
There has been no final dividend for Galapagos.
Galapagos N.V., listed on the Amsterdam Stock Exchange under the symbols GLPG, does not pay dividends to its shareholders and so far the company has not provided information on a change in this policy in the short term.
Join +33,000 investors who get notifications, analysis and news.
Payout Ratio Galapagos Dividends
Dividend calendar of Galapagos
There is no Dividend Calendar of Galapagos defined for 2023.
Historical annual dividend yields of Galapagos
Dividend yield of Galapagos vs. the sector
Dividend yield history in Galapagos
Dividend history of Galapagos
Galapagos has never distributed dividends, so it has an empty dividend history.
Galapagos dividend capture strategy
Information about Galapagos
Galapagos N.V., is a Belgian company dedicated to research issues related to the development of medicines and drugs for the treatment of Crohn's disease, rheumatoid arthritis, psoriasis, ulcerative colitis, cystic fibrosis and systemic lupus erythematosus.
The purpose of the organization is to seek quality of life for its patients through the use of biotechnology, offering its clients the development and commercialization of drugs covering immunological procedures, oncological therapies, cellular therapies and others.
It was founded in 1999 through a partnership between Crucell and Tibotec, starting to be listed on Euronext Brussels and Amsterdam in 2005, extending its operations to France the following year, they bought and sold some other companies, but as of 2014 it focuses solely on its current research and development line.
In 2020 they receive authorization to market Jyseleca®, a drug for rheumatoid arthritis, which can be distributed and sold in the European Union, Japan and Great Britain, getting the following year another permit to market its drug against ulcerative colitis.
In 2022 they acquired CellPoint and AboundBio, thus diversifying their activities into next-generation cell therapy, achieving a therapeutic platform based on the use of human antibodies.
Their headquarters are located in Belgium, although they are located in the Netherlands, Germany, Italy, France, Switzerland, Austria, the United Kingdom, the Nordic countries and the United States, with more than 1,200 employees.
Frequently asked questions about Galapagos dividends
Galapagos is listed on the Bolsa de Amsterdam and is part of the AMX.
Galapagos has the Ticker or stock code GLPG.
Galapagos belongs to the Health Care sector and the Biotechnology industry.
The CEO of Galapagos in 2023 is Dr. Paulus A. Stoffels M.D., Ph.D..
At this moment, the value of a Galapagos share is 33.86€.
Galapagos does not have a growing dividend program. Dividends have not shown a steady growth in the last 5 years.